Intranasal administration of mesenchymoangioblast-derived mesenchymal stem cells abrogates airway fibrosis and airway hyper-responsiveness associated with chronic allergic airways disease
The above paper was done in Australia showing how iPSC MSC can be use to repair lung tissues and airwasy in 2017.
